Cellular_JJ
disposition_NN
of_IN
sulphamethoxazole_NN
and_CC
its_PRP$
metabolites_NNS
:_:
implications_NNS
for_IN
hypersensitivity_NN
._.

1_LS
._.
Bioactivation_NN
of_IN
sulphamethoxazole_NN
-LRB-_-LRB-
SMX_NN
-RRB-_-RRB-
to_TO
chemically-reactive_JJ
metabolites_NNS
and_CC
subsequent_JJ
protein_NN
conjugation_NN
is_VBZ
thought_VBN
to_TO
be_VB
involved_VBN
in_IN
SMX_NN
hypersensitivity_NN
._.

We_PRP
have_VBP
therefore_RB
examined_VBN
the_DT
cellular_JJ
metabolism_NN
,_,
disposition_NN
and_CC
conjugation_NN
of_IN
SMX_NN
and_CC
its_PRP$
metabolites_NNS
in_FW
vitro_FW
._.

2_LS
._.
Flow_NN
cytometry_NN
revealed_VBD
binding_NN
of_IN
N-hydroxy_NN
-LRB-_-LRB-
SMX-NHOH_NN
-RRB-_-RRB-
and_CC
nitroso_NN
-LRB-_-LRB-
SMX-NO_NN
-RRB-_-RRB-
metabolites_NNS
of_IN
SMX_NN
,_,
but_CC
not_RB
of_IN
SMX_NN
itself_PRP
,_,
to_TO
the_DT
surface_NN
of_IN
viable_JJ
white_JJ
blood_NN
cells_NNS
._.

Cellular_JJ
haptenation_NN
by_IN
SMX-NO_NN
was_VBD
reduced_VBN
by_IN
exogenous_JJ
glutathione_NN
-LRB-_-LRB-
GSH_NN
-RRB-_-RRB-
._.

3_LS
._.
SMX-NHOH_NN
and_CC
SMX-NO_NN
were_VBD
rapidly_RB
reduced_VBN
back_RB
to_TO
the_DT
parent_JJ
compound_NN
by_IN
cysteine_NN
-LRB-_-LRB-
CYS_NN
-RRB-_-RRB-
,_,
GSH_NN
,_,
human_JJ
peripheral_JJ
blood_NN
cells_NNS
and_CC
plasma_NN
,_,
suggesting_VBG
that_IN
this_DT
is_VBZ
an_DT
important_JJ
and_CC
ubiquitous_JJ
bioinactivation_NN
mechanism_NN
._.

4_LS
._.
Fluorescence_NN
HPLC_NN
showed_VBD
that_IN
SMX-NHOH_NN
and_CC
SMX-NO_NN
depleted_VBD
CYS_NN
and_CC
GSH_NN
in_IN
buffer_NN
,_,
and_CC
to_TO
a_DT
lesser_JJR
extent_NN
,_,
in_IN
cells_NNS
and_CC
plasma_NN
._.

5_CD
._.
Neutrophil_NN
apoptosis_NN
and_CC
inhibition_NN
of_IN
neutrophil_NN
function_NN
were_VBD
induced_VBN
at_IN
lower_JJR
concentrations_NNS
of_IN
SMX-NHOH_NN
and_CC
SMX-NO_NN
than_IN
those_DT
inducing_VBG
loss_NN
of_IN
membrane_NN
viability_NN
,_,
with_IN
SMX_NN
having_VBG
no_DT
effect_NN
._.

Lymphocytes_NNS
were_VBD
significantly_RB
-LRB-_-LRB-
P_NN
&lt;_JJR
0.05_CD
-RRB-_-RRB-
more_RBR
sensitive_JJ
to_TO
the_DT
direct_JJ
cytotoxic_JJ
effects_NNS
of_IN
SMX-NO_NN
than_IN
neutrophils_NNS
._.

6_LS
._.
Partitioning_NN
of_IN
SMX-NHOH_NN
into_IN
red_JJ
blood_NN
cells_NNS
was_VBD
significantly_RB
-LRB-_-LRB-
P_NN
&lt;_JJR
0.05_CD
-RRB-_-RRB-
lower_JJR
than_IN
with_IN
the_DT
hydroxylamine_NN
of_IN
dapsone_NN
._.

7_LS
._.
Our_PRP$
results_NNS
suggest_VBP
that_IN
the_DT
balance_NN
between_IN
oxidation_NN
of_IN
SMX_NN
to_TO
its_PRP$
toxic_JJ
metabolites_NNS
and_CC
their_PRP$
reduction_NN
is_VBZ
an_DT
important_JJ
protective_JJ
cellular_JJ
mechanism_NN
._.

If_IN
an_DT
imbalance_NN
exists_VBZ
,_,
haptenation_NN
of_IN
the_DT
toxic_JJ
metabolites_NNS
to_TO
bodily_JJ
proteins_NNS
including_VBG
the_DT
surface_NN
of_IN
viable_JJ
cells_NNS
can_MD
occur_VB
,_,
and_CC
may_MD
result_VB
in_IN
drug_NN
hypersensitivity_NN
._.

